Spinocerebellar ataxia type 1 (
SCA1) is an autosomal-dominant
neurodegenerative disorder characterized by
ataxia and progressive motor deterioration.
SCA1 is caused by expansion of the
polyglutamine tract in the
SCA1 gene product,
ataxin-1. We previously reported that the
E2 ubiquitin-conjugating enzyme UbcH6 interacts with and ubiquitinates the
ataxin-1 proteins as an E2-substrate cognate pair in the
ubiquitin-
proteasome system. In the present study, we further investigated whether the function of
ataxin-1 is associated with UbcH6 and found that UbcH6 regulates the transcriptional repression activity of
ataxin-1. The overexpression of UbcH6 reduced the transcriptional repression activity of
ataxin-1. Interestingly, ataxin-1(30Q) was more affected by the presence of UbcH6 than ataxin-1(82Q), implying that the length of the
polyglutamine tract in
ataxin-1 might be involved in determining the stability of
ataxin-1. The half-life of ataxin-1(82Q) was longer than that of ataxin-1(30Q) in the presence of UbcH6. shRNAs targeting UbcH6 enhanced the transcriptional repression activity of
ataxin-1. In addition, the overexpression of UbcH6 reduced the formation of
ataxin-1 aggregates. Our studies demonstrate that UbcH6 modulates the transcriptional repression activity of
ataxin-1 by modulating the degradation of
ataxin-1, suggesting that UbcH6 may have some therapeutic potential in the treatment of
SCA1.